.
MergerLinks Header Logo

New Deal


Announced

XIFIN to acquire OmniSYS from NexPhase Capital.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Single Bidder

Pending

Online and Social Platforms

retail pharmacy

Friendly

Private

Domestic

Majority

United States

Private Equity

Synopsis

Edit

XIFIN, a healthcare information technology company, agreed to acquire OmniSYS, a provider of technology solutions for the retail pharmacy industry, from NexPhase Capital, a thematic and operationally-focused private equity firm. Financial terms are not disclosed. “The healthcare industry is experiencing an important transformation in care access. As pharmacies expand their scope, more care opportunities are opening up for patients, as well as valuable partnership opportunities for diagnostic laboratories. The integration of disparate systems to benefit our customers and their patients has always been XIFIN’s fundamental technology driver, and the addition of OmniSYS broadens our value proposition for both independent diagnostic providers and hospitals. As clinical services increase in the pharmacy setting, we will enable connectivity between consumers and other ancillary diagnostic providers, which is essential to coordinating care and optimizing personalized medicine. For hospitals and health systems, XIFIN can provide combined solutions and services across many of their key ancillary services departments – laboratory/pathology, radiology and now, pharmacy,” Lâle White, XIFIN Executive Chairman and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US